Thanks Boyfromoz,
And yes, that is still a vague answer - not directly answering your question of if they're selling the product. In which case perhaps Akai got samples from them (hence he's saying he only has a certain number of vials left)?????? At any rate it sounds a bit dodgy. I wish Histogen would be a bit more outright in their reply. Perhaps I'll write to them telling them I wanted to try this with Akai and send my email correspondence with Akai and ask if they're legit in selling it and see if they respond. Pretty busy now though so many not get to it till after Xmas. But if I do and hear anything back I'll let you know.

I agree with what you suggested sunrise.

If anyone is seriously thinking about doing this, write to Histogen first and ask directly about "dr" Akai.

There are too many money grabbing grubs out there who will take advantage of us.

Yeap, sounds like they have no connection with what he's selling. Akai is a scam. Histogen is not selling anything. The answer is not vague, your over thinking it. There are no sanctioned studies in japan, and they can not sell it yet.

Lets move on please.

-------------------------
F@(K it! No treatments. Nothing. Im done wasting money.
Dr. Thomas (scum) Wentland-1800 hairs, destroyed my life.
Dr. Ron Shapiro- 176 FUE into scar. Happy with results.
Buzzing my head no guard, happy except for the marks left from scumland, i mean Dr. wentland.

i also had a response from histogen

Thank you for your interest and message. Please excuse the delay in my response, we are working through a large number of inquiries.

Thank you for sharing that link. Histogen is in discussions with physicians in Japan regarding HSC clinical studies, however there are no Histogen-sponsored studies ongoing in Japan at this time. We are aware of the advertising around these clinics, and have asked that HSC be removed from their websites, etc. In most cases, this has been done.

Hage, have you reported "Dr" Akai to the appropriate authorities? He is obviously a scammer.

I really think you should to protect others in our situation. You should also take legal action to get your money back.

So are we all in agreement that this Dr. Akai is a fraud and not selling the real deal?



-------------------------
Maxster

I agree with that assessment.

i dont like the story with the japanese doctors, who tells me that they didnt bought the vials from some poor asian doctor who was participating on the trial ???

blaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa

-------------------------
A young hair loss sufferer at 20 , with a receeding hairline. Im gonna start with Nisim new hair biofactors soon. It because my scalp and my hairline itches so much no matter how i wash it. I have tried nizoral and it didnt help , so nisim claims that it helps against genetic hairloss too ,we shall see. I tried minoxidil before but with a itchy hairline and scalp my hairline became itchy and worse. I want to try propecia but the risks and side effects everyone tells seen to scare me.

Edited: 05/15/2012 at 09:33 AM by Therealist

lol they can sue you now

hage do have any papers or anything else u can show us to proove this? I have japanese background myself its is not in culture to lie , but i would like it if u can proove it.

-------------------------
A young hair loss sufferer at 20 , with a receeding hairline. Im gonna start with Nisim new hair biofactors soon. It because my scalp and my hairline itches so much no matter how i wash it. I have tried nizoral and it didnt help , so nisim claims that it helps against genetic hairloss too ,we shall see. I tried minoxidil before but with a itchy hairline and scalp my hairline became itchy and worse. I want to try propecia but the risks and side effects everyone tells seen to scare me.

LOL i believe everyone gets that.

-------------------------
A young hair loss sufferer at 20 , with a receeding hairline. Im gonna start with Nisim new hair biofactors soon. It because my scalp and my hairline itches so much no matter how i wash it. I have tried nizoral and it didnt help , so nisim claims that it helps against genetic hairloss too ,we shall see. I tried minoxidil before but with a itchy hairline and scalp my hairline became itchy and worse. I want to try propecia but the risks and side effects everyone tells seen to scare me.

that japanese story was false.... the clinic was a fraud. Someone from hairsite sent an email to histogen about that and they said that there is no way that anyone besides them have access to HSC

http://www.medicalnewstoday.com/articles/244346.php

has anyone read about this i havent seen anyone post this on the forum.

-------------------------
A young hair loss sufferer at 20 , with a receeding hairline. Im gonna start with Nisim new hair biofactors soon. It because my scalp and my hairline itches so much no matter how i wash it. I have tried nizoral and it didnt help , so nisim claims that it helps against genetic hairloss too ,we shall see. I tried minoxidil before but with a itchy hairline and scalp my hairline became itchy and worse. I want to try propecia but the risks and side effects everyone tells seen to scare me.

What is going on with Histogen ? Any news?

http://clinicaltrials.gov/beta...istogen&Search=Search

Enrollment: 56
Study Start Date: December 2011
Estimated Study Completion Date: December 2012

Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)

Gail said there will be a update in October.

http://www.histogen.com/aboutus/news_events.htm#37

Histogen got its method patented.

Time to sell the house.

Histeogen Announces Initial Results from Phase 1/2 Clinical Trial on Oct 19

http://www.histogen.com/aboutus/news_events.htm

Histogen Announces Initial Results from Phase I/II Clinical Trial of HSC
Data shows significant efficacy at all time points and all treated hair loss regions
SAN DIEGO, October 19, 2012 - Histogen, Inc., a regenerative medicine company developing innovative therapies based on the products of cells grown under simulated embryonic conditions, will present preliminary data from the ongoing clinical trial of its Hair Stimulating Complex (HSC) today at the International Society of Hair Restoration Surgery (ISHRS) Annual Meeting. Statistically significant improvement was seen across all targeted hair growth parameters in this Phase I/II clinical trial, with an 86% responder rate.
The double-blind Phase I/II clinical trial was undertaken to further examine the safety and efficacy of intradermal injections of HSC in 56 men with androgenetic alopecia. In addition to other safety outcome measures, clinical evaluation of blood serum chemistry, hematology and urinalysis showed no indication of toxicity over 12 weeks. The treatment was well-tolerated and no study-related adverse events have been reported.
In this second clinical trial of HSC, which was designed with an additional treatment timepoint, the increase in total hair count was 46.5% above that seen in the pilot HSC trial at 12 weeks. Statistical significance was noted in all efficacy endpoints, which include increases in total hair count (p=0.0013), terminal hairs (p=0.0135), and hair thickness (p=0.026). A significant increase in vellus hair count (p=0.033) was seen for the first time, supporting the hypothesis that the HSC treatment rescues dying follicles, in addition to converting vellus to terminal hairs and increasing the number of hairs per follicle. Statistical significance continued to be seen at the 24 week time point.
"We are excited that HSC has not only continued to show unprecedented results, but that the addition of a second treatment time point in the Phase I/II clinical trial has resulted in even greater hair growth than the pilot study," said Gail K. Naughton, Ph.D., Histogen CEO and Chairman of the Board. "Particularly compelling is the growth seen in more difficult types and stages of hair loss. Without limitations to treatment area, age or stage of balding, HSC has the potential to expand the hair restoration market by offering a successful option to those that currently have none."
Available non-surgical treatment options for alopecia focus on younger patients in the earlier stages of hair loss, with a primary purpose of retaining existing hair and supporting limited hair regrowth. This is not the trend seen in the clinical trials of HSC. In both the pilot and Phase I/II clinical trial, HSC treatment has shown efficacy across age groups, with subjects age 40-59 seeing cosmetically significant results beginning at 12 weeks, including a mean increase of 39% in terminal hairs and 19.4% in total hair count in this age group in the current trial.
Importantly, the efficacy of HSC is not limited by hair loss region. The Phase I/II clinical trial has shown noted new hair growth in subjects treated in all regions of the scalp, including temporal recession, mid-scalp and vertex. Subjects receiving HSC in the temporal recession, which is known to be more difficult to treat than other areas of hair loss, saw marked improvement in terminal hair count, with a mean increase of 22.6% at 12 weeks and 25.2% at the 24 week time point.
In addition to the Phase I/II data, Dr. Naughton will present results from a Physician-sponsored IND of HSC conducted by Dr. Craig Ziering, an ISHRS member and leading hair restoration surgeon. Five men and five women received up to four treatments of HSC, with all subjects showing positive hair growth. Increased hair growth was seen as early as 6 weeks, with clinically and cosmetically relevant results seen as early as 18 weeks.
"The clinical data seen to date with HSC is very compelling," said Dr. Craig Ziering, Founder and CEO of Ziering Medical. "Not only is the strong safety profile clinically important, but we have seen cosmetically significant results, with coverage of thinning areas, in a clinical setting. In addition, the response seen in women treated with HSC is unprecedented."
HSC is a complex of proteins and growth factors naturally secreted by multipotent cells under Histogen's proprietary growth conditions. The proteins within HSC, such as KGF, VEGF, and follistatin, are involved in signaling stem cells in the body, and have been shown to be key in hair formation and the stimulation of resting hair follicles.
"Scalp Injection of Active Embryonic-like Cell-secreted Proteins and Growth Factors" will be presented by Dr. Naughton at the ISHRS Annual Meeting, taking place October 17-20, 2012, in the Bahamas.